MAnagement of METastatic Disease in Campania (MAMETIC)

National Cancer Institute, Naples

Status: Completed

Conditions: Metastatic Disease

Treatments: Device: 3DCRT, IMRT, VMAT, SBRT

Study type: Observational

Funder types: Other

Identifiers

NCT04595032

33/20 oss

Details and patient eligibility

About

The MAMETIC Trial represents the first regional epidemiological study that aims to evaluate patients living in Campania with metastatic cancer, with the intent to detect different prevalence of tumors in the metastatic phase and evaluate the local response to the patient's request for assistance.

Condition or disease: Metastatic disease Intervention/treatment: Radiation Treatment

Full description

The MAMETIC Trial is a multicenter, retrospective and prospective observational study and 17 of 20 RT Centers in Campania joined it.

1. The retrospective part of the study concerns all patients enrolled with a diagnosis of metastatic disease and treated in RT centers of the Campania Region with 3DCRT, IMRT, VMAT, SBRT techniques from January 2019 to August 2020. In 2019, it has been enrolled 12.500 patients in the 17 RT Centers and it is estimated that 20-30% of the above mentioned patients had metastasis. Thus, approximately 2.560 patients are expected to be enrolled.
2. The prospective part of the study is going to enroll all metastatic patients eligible for palliative RT, treated in RT Centers of the Campania region with 3DCRT, IMRT, VMAT, SBRT techniques from September 2020 to September 2025. Considering the RT Centers that joined the trial, it is expected to enroll approximately 2.500-4.200 patients per year and a total of 12.500-21.000 patients in 5 years.

The study will last 61 months, divided as follow: 60 months of enrollment phase and up to 1 month of follow-up for pain and bone metastasis patients. Follow-up will be performed on the 15th and 30th day after the end of radiation treatment.

Enrollment: 3,234 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged > 18 years resident in Campania Region;
• Patients diagnosed with metastatic disease candidates for radiotherapy
• Metastatic patients candidates for radiotherapy re-treatment
• Oligometastatic patients candidates for radiotherapy; Patients who have given their consent

Exclusion criteria

• Patients aged < 18 years
• Patients who are unable to express consent to sensitive data and radiant treatment